The endoplasmic reticulum (ER) is a cellular organelle important for regulating calcium homeostasis, lipid metabolism and protein synthesis, post-translational modification and trafficking. Numerous environmental, physiological and pathological insults disturb ER homeostasis, referred to as ER stress, in which a collection of conserved intracellular signaling pathways termed the unfolded protein response (UPR) are activated to maintain ER function for cell survival. However, excessive and/or prolonged UPR activation leads to initiation of self-destruction through apoptosis. Excessive accumulation of lipids and their intermediate products causes metabolic abnormalities and cell death, called lipotoxicity, in peripheral organs, including the pancreatic islets, liver, muscle and heart. Since accumulating evidence links chronic ER stress and defects in UPR signaling to lipotoxicity in peripheral tissues, understanding the role of ER stress in cell physiology is a topic under intense investigation. In this review, we highlight recent findings that link ER stress and UPR signaling to the pathogenesis of peripheral organs due to lipotoxicity.
Introduction
The ER is a central organelle where proteins destined for the cell surface and the endomembrane system enter the secretory pathway. Once inside the ER lumen, newly synthesized polypeptides fold into their three-dimensional structures, assemble into higher order multimeric complexes and are subject to post-translational modifications such as glycosylation, hydroxylation, lipidation, and disulfide formation. The ER contains an extremely high Ca 2+ concentration (1) , which is maintained by the active transport function of the Sarco/Endoplasmic reticulum calcium ATPase (SERCA) (2) .
Many ER chaperone proteins and enzymes depend on higher Ca 2+ levels to facilitate protein folding and maturation (3) . Therefore, maintaining ER homeostasis is essential for proper protein production and cell function. Homeostasis in the ER is disrupted by a number of insults, including pharmacological perturbation, genetic mutation of ER chaperones or their client proteins, elevated expression of proteins that transit the endomembrane system, viral infection, alterations in Ca 2+ or redox status, and limited or excessive available nutrients such as lipids. The accumulation of unfolded or misfolded proteins in the ER lumen activates a set of intracellular signaling pathways known as the UPR (4, 5) . The UPR regulates the quantity of ER driven by synthesis of lipids (6) and protein components of the ER to accommodate fluctuating demands on protein folding and other ER functions in response to different physiological and pathological conditions.
The ER is also the major site for the synthesis of sterols and phospholipids that constitute the bulk of the lipid components of all biological membranes. In addition, many enzymes and regulatory proteins involved in lipid metabolism reside in the ER.
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and membrane lipid homeostasis in all cell types. Fat accumulates in the presence of excessive caloric uptake to serve as an energy store. Adipocytes are specialized cells that store excess lipids. However, lipid overloading of adipocytes causes lipids to accumulate in non-adipose tissues including the pancreas, liver, muscle, and heart, causing cell dysfunction and associated pathologies. This lipotoxicity is a fundamental contributor to metabolic disease and insulin resistance (8, 9) . Given the pivotal role of the ER in lipid metabolism, it is important to understand the linkage between ER homeostasis and lipotoxicity.
ER stress and the UPR
In mammals, the UPR is signaled through activation of three ER transmembrane ER stress sensors (Fig 1) : 1) inositol-requiring enzyme 1 α (IRE1α); 2) the double-stranded RNA-activated protein kinase (PKR)-like eukaryotic initiation factor 2α kinase (PERK); and 3) activating transcription factor 6α (ATF6α) (10) . The UPR sensors are all maintained in an inactive state through interaction between their ER luminal domains with the protein chaperone immunoglobulin heavy-chain binding protein (BiP; also known as GRP78 and HSP5A). When unfolded/misfolded proteins accumulate in the ER lumen upon ER stress, they bind to and sequester BiP, thereby promoting BiP dissociation and initiating downstream signaling (11) (12) (13) .
Once released from BiP, PERK is activated through homodimerization and transautophosphorylation (14) . Activated PERK phosphorylates the alpha subunit of the eukaryotic translation initiation factor 2 (eIF2α) at Ser51 leading to rapid and transient inhibition of protein synthesis (14, 15 including the transcription factor activating transcription factor 4 (ATF4) (16) . ATF4 promotes expression of its target genes including the growth arrest and DNA damageinducible protein 34 (GADD34; also known as PPP1R5A) to dephosphorylate eIF2α
and restore global mRNA translation (17) . ATF4 also activates transcription of the C/EBP homologous protein (CHOP; also known as DDIT3 and GADD153), which is essential for the apoptotic response to ER stress (18) (19) (20) (27) .
ER stress and lipid metabolism
The ER is the major site of lipid metabolism as many enzymes involved in lipid metabolism are located in the ER. Although the UPR was originally identified to maintain the protein homeostasis in the ER, a number of studies suggest that the UPR plays essential roles in maintaining the metabolic and lipid homeostasis (Fig 2) . For example, forced expression of BiP in the liver attenuates hepatic steatosis and improves glucose homeostasis by inhibiting activation of the central lipogenic regulator SREBP1c, suggesting ER stress has a pivotal role in hepatic lipid metabolism (28) .
Cross talk between ER stress and lipid metabolism is evident from the finding that S1P
and S2P processing enzymes also cleave and activate the sterol-response element binding proteins SREBP-1c and SREBP-2 that regulate biosynthesis of cholesterol and other lipids. It should also be noted that protein misfolding in the ER causes oxidative stress that can lead to apoptosis (29) . In addition, antioxidant treatment can prevent oxidative stress, reduce apoptosis and even improve protein folding (30, 31) . Although the mechanism that connects protein misfolding with oxidative stress is unknown, it might involve Ca 2+ flux to regulate mitochondrial oxidative phosphorylation, increased fatty acid oxidation, oxidation of free sulfhydryls during disulfide bond formation in the ER, the induction of oxidases, such as nitric oxide synthase, or inhibition of antioxidant responses (32) . The IRE1α/XBP1 pathway was identified as a critical regulator of hepatic lipid metabolism. Hepatocyte-specific Ire1α deletion increased hepatic lipid levels and reduced plasma lipids by modulating several genes involved in lipid metabolism including C/ebpβ, C/ebpδ, Pparγ, and enzymes involved in TG biosynthesis (42) . In addition, XBP1s was shown to directly regulate lipogenic genes in the liver including Dgat2, Scd1, and Acc2 (43) . Specific deletion of Xbp1 in the liver compromised de novo hepatic lipogenesis, leading to reduced serum TG, cholesterol, and free fatty acids (43) . Interestingly, hepatocyte-specific Ire1α deletion did not alter lipogenesis, but rather specifically impaired VLDL assembly and secretion, leading to hepatosteotosis and hypolipidemia (42, 44) . In the absence of IRE1α, there was reduced protein disulfide isomerase (PDI), which acts with microtriglyceride transfer protein to promote the delivery of neutral lipids to the smooth ER lumen for VLDL assembly (45) .
Therefore, there is some controversy as to how ER stress affects lipid accumulation and/or secretion through the IRE1α/XBP1 pathway. This discrepancy can be explained by the finding that IRE1α is hyperactivated in liver-specific Xbp1-/-mice (46). IRE1α induces degradation of certain mRNAs, a process known as regulated IRE1-dependent decay (RIDD) (47, 48) . Hyperactivated IRE1α in liver-specific Xbp1-/-promoted degradation of mRNAs encoding lipid metabolism functions, thereby reducing plasma TG and cholesterol in these mice (46) . In addition to lipid metabolism, IRE1α/XBP1 also induces expression of many inflammatory cytokines and Xbp1 deletion or small molecule inhibition of IRE1α has demonstrated anti-inflammatory effects (49-51).
The ATF6α pathway also plays a role in stress-induced lipid accumulation. p50ATF6α Alternatively, different species may have evolved to utilize these pathways for different functions to cope with their specific environmental challenges.
ER stress and lipotoxicity in peripheral organs

Pancreatic β cells
Chronically elevated levels of free fatty acid (FFA) in vitro or in vivo are detrimental to pancreatic β cell function. Saturated fatty acids (SFAs), such as palmitate, activate the UPR with subsequent induction of apoptosis compared to unsaturated fatty acids such as oleate, suggesting a harmful effect of SFAs (56) . Damage driven by prolonged exposure to SFAs in pancreatic β cells was believed to be a main cause of type 2 diabetes (57-59). Their cytotoxic effect was attributed to an increased lipogenesis in β cells (60) or upregulation of inducible nitric oxide syntheses (iNOS) followed by NO- On the other hand, palmitate treatment activated autophagy in insulinoma cells to prevent lipotoxicity (80) . An islet transcriptome study using RNA sequencing in palmitate-treated human islets identified that palmitate modulates expression of genes involved in autophagic flux and lysosome function (81) . When autophagy was inhibited by chloroquine, ER stress was induced in isolated islets (82) . In addition, autophagy induced by interleukin-22 (IL-22) alleviated palmitate-induced ER stress in insulinoma cells (83) . These results suggest that activation of autophagy by palmitate or HFD feeding prevents ER stress-mediated pancreatic β cell death. Interestingly, JNK activity, which is associated with ER stress, also appears to be involved in β cell death upon palmitate-induced ER stress. When JNK1 activity was attenuated using JNK1 shRNA in insulinoma cells, apoptosis was decreased with reduced levels of CHOP protein upon palmitate treatment (84) . In addition, palmitate-induced β cell death was attenuated by metformin, an insulin sensitizer, by suppressing ER stress (85) .
High density lipoprotein (HDL) is a potential inhibitor of ER stress-mediated cell death
especially in pancreatic β cells. Thapsigargin, a SERCA inhibitor, caused disruption of the Ca 2+ gradient between the ER and the cytosol and thus induced ER stress-mediated apoptosis, which was attenuated by HDL treatment (86) . HDLs also prevented palmitate-induced UPR induction and ER stress and β cell death through restoration of ER functionality in terms of protein folding and trafficking (86 Of note, TUDCA was reported to reduce symptoms of type 1 and type 2 diabetes in murine models (89, 90) . However, intriguingly, this protection in type 1 diabetes required ATF6α function and was lost in mice with β cell-specific deletion of Atf6α (89). This is curious because since TUDCA should prevent UPR activation, why would this response require activation of ATF6α. Nevertheless, this data provides an in vivo, correlate for effects in cultured β cell studies.
Liver
Several lines of evidence suggest that ER stress is one of important contributing factor for SFA-mediated lipotoxicity in the liver (Fig 3) . accumulation and ER stress in the liver from HFrD-fed mice (108) . Interestingly,
another PPARα agonist fenofibrate (FB) also improved hepatic insulin resistance and steatosis in HFrD-fed mice, but in this case ER stress was still upregulated (109) .
Therefore, the role of PPARα in ER stress-mediated lipotoxicity remains to be elucidated. In old mice, TG was markedly accumulated and lipogenic genes were deregulated by ER stress-mediated down-regulation of farnesoid X receptor (FXR) (110) that plays a pivotal role in the regulation of hepatic TG metabolism (111) . TUDCA and 4-PBA treatment in old mice reduced ER stress marker expression but increased FXR expression with reduced hepatic TG content, suggesting a protective role for FXR in ER stress-mediated lipotoxicity. Further studies are needed to understand the relationship between ER stress and orphan nuclear receptors.
Alteration in autophagic flux may also contribute palmitate-induced ER stress. In livers from patients with non-alcoholic fatty liver (NAFLD) or non-alcoholic steatohepatitis (NASH), there was increased ER stress gene expression with decreased autophagic flux (112) . Consistently, palmitate treatment in Huh7 cells increased ER stress associated with decreased autophagy, which was restored with an autophagy inducer rapamycin (112) .
Skeletal muscle
Lipotoxicity in muscle may also be mediated by ER stress (Fig 3) , evidenced by a range of studies from in vitro to human studies. For in vitro studies, palmitate treatment in cultured human myotubes induced ER stress markers and decreased cell viability which was attenuated by overexpression of SCD1 (113) . Interestingly, SCD1 inducibility upon palmitate treatment was different in individual human myotubes. Higher SCD1
induction was associated with a reduced ER stress response and better insulin sensitivity, whereas myotubes with lower SCD1 induction showed more ER stress marker gene expression (113), suggesting SFA-mediated ER stress causes muscle cell dysfunction.
The relationship between ER stress and lipotoxicity was also demonstrated in skeletal muscle. When mice were fed HFD, the expression levels of ER stress marker genes including BiP, the spliced form of XBP1 and ATF4/CHOP were markedly increased in skeletal muscle (114) . In human studies, TUDCA (115) and 4-PBA (116), chemical chaperones that relieve ER stress, improved muscle insulin sensitivity in obese patients, strongly suggesting that lipotoxicity in skeletal muscle is mediated by ER stress. In addition to chemical chaperones, palmitate-induced lipotoxicity was also prevented by attenuation of ER stress using oleate treatment (116, 117) , or PPARβ/δ activation through AMPK activation (118) . These results suggest a pivotal role for ER stress in palmitate-induced lipotoxicity in skeletal muscle and that attenuating ER stress might ameliorate lipotoxicity in skeletal muscle.
However, there are several contradictory reports indicating that ER stress has little association with lipid-induced skeletal myocyte dysfunction. No significant change in by guest, on October 22, 2017 www.jlr.org
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ER stress marker gene expression resulting from TUDCA treatment was observed despite of improved liver and skeletal muscle function compared to placebo treated patients (115) . In addition, muscle tissues from HFD-fed patients did not show significant induction of ER stress (119) . In other reports, it was found that ER stress was moderately induced in response to palmitate compared to treatment with pharmacological ER stress inducers (120) . Treatment with chemical chaperones did not improve palmitate-induced insulin sensitivity in myotubes (121) . Therefore, the role of ER stress in palmitate-induced lipotoxicity in skeletal muscle remains unclear and further studies are required.
Heart
Unlike other tissues, cardiomyocytes in the adult heart preferentially use fatty acids to meet their high energy requirement, suggesting an importance of lipid metabolism in the heart. On the other hand, myocardial TG accumulation is often associated with impaired cardiac function. Intracellular TG accumulation was observed in stressed hearts and this was regarded as a hallmark of cardiac lipotoxicity that eventually leading heart failure (122, 123) . It is of note that specific cardiac conditions such as pressure overload (124) or ischemia (125) cause ER stress that likely contributes to cardiomyocyte dysfunction upon stress-mediated lipid accumulation (Fig 3) . Recent studies support this hypothesis, in which hypoxia/ischemia-induced lipid accumulation in HL-1 cardiomyocytes and mouse hearts was dependent on expression of the VLDL receptor (VLDLR) (126) . It was found that ischemia-induced ER stress and subsequent apoptosis in mouse heart were reduced in Vldlr-/-mice and in mice treated with antibodies against VLDLR (126) .
These results suggest that VLDLR-induced lipid accumulation in the ischemic heart cause cell death through activation of ER stress. In another report, myocardial ischemia in a pig model increased intracellular cholesteryl ester levels, which in turn activated the UPR and ER stress accompanied by myocardial dysfunction (127) .
In Golgi apparatus for cleavage by S1P and S2P, which release p50ATF6α that transcriptionally induces its target genes encoding ER chaperone and ERAD functions. 
